Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-576-1 | CAS number: 12012-35-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The NOAEL for oral repeated dose toxicity was obtained from a study in which rats were fed chromium(III) oxide baked in bread for 90 days. No signs of toxicity were observed even at the highest dose.
The LOAEC for inhalation was derived from a guideline subchronic inhalation study with chromium(III) oxide. At the lowest concentration slight inflammation was observed in the lungs.
Due to the low bioavailability of chromium, the dermal route is not relevant for repeated dose toxicity.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 368 mg/kg bw/day
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Dose descriptor:
- LOAEC
- 3 mg/m³
Additional information
No data were available on repeated dose toxicity tests with trichromium dicarbide, and therefore the read-across approach was used. Dissolution studies utilizing various synthetic body fluids have shown similar release profiles for chromium carbide and chromium metal and chromium(III) oxide.
No signs of toxicity were observed in an oral rat study with chromium(III) oxide, although the doses used were relatively high. The results are obviously due to the water-insolubility and poor oral bioavailability of chromium(III)oxide. The NOAEL 1368 mg Cr(III)/kg/bw obtained with chromium(III) oxide can be directly adopted for trichromium dicarbide.
Mild inflammatory reactions were observed with chromium(III) oxide in male and female rats in a 13 -week subchronic inhalation study at all exposure levels. These slight inflammatory changes are likely to be a reflection of a non-specific lung response caused by particle overload, rather than being a response of intrinsic toxicity of trivalent chromium. According to these studies the LOAEC for chromium(III) oxide is 4.4 mg/m3 (corresponding to 3 mg Cr(III) /m3), which is in fact most likely not much higher than the NOAEC for chromium(III) oxide in rats, as the severity and frequency of inflammatory changes in the lungs were minimal. No systemic adverse effects were observed in the inhalation study. The LOAEC of 3 mg Cr(III) /m3 can be used for chromium metal, as its surface is always auto-oxidized to chromium(III) oxide and therefore, in the case of fine chromium dusts, a large proportion of the chromium is in the form of chromium(III)oxide.
No studies were available on the repeated dose toxicity of chromium carbide, chromium metal or trivalent chromium compounds via the dermal route. As trichromium dicarbide is practically insoluble in various synthetic biological fluids, it does not pass through the skin or enter the systemic circulation, and repeated dose toxic effects via the skin are therefore not expected.
Repeated dose toxicity: inhalation - systemic effects (target organ) respiratory: lung
Justification for classification or non-classification
Repeated exposures of chromium(III) oxide via the oral or inhalation routes have not resulted in any signs of systemic toxicity. Dissolution studies have shown similar release profiles for chromium carbide, chromium metal and chromium(III) oxide. Therefore the results obtained with chromium(III) oxide can directly be adopted for trichromium dicarbide.
Mild local effects were observed in rats after repeated inhalation of chromium(III) oxide. These slight effects were most likely non-specific, caused by accumulation of insoluble particles. Rat lungs are known to be sensitive to particle overload, and inflammation is an expected outcome of rat inhalation studies with insoluble particles.
A DNEL for local effects caused by inhalation was derived, but there is no need to suggest classification for this endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.